Trastuzumab, non-pegylated liposomal-encapsulated doxorubicin and paclitaxel in the neoadjuvant setting of HER-2 positive breast cancer
Crossref DOI link: https://doi.org/10.1007/s11096-016-0278-5
Published Online: 2016-03-07
Published Print: 2016-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Uriarte-Pinto, Moisés
Escolano-Pueyo, Ángel
Gimeno-Ballester, Vicente
Pascual-Martínez, Oihana
Abad-Sazatornil, María Reyes
Agustín-Ferrández, María José
Text and Data Mining valid from 2016-03-07